Stock Ratings / Health Care / MOBI / financials

EMBC (74) CLPT (34) OFIX (55) SI (42) ⌘ Pro Terminal →

Mobia Medical Inc. (MOBI) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

$11.27 -4.41% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $11.16

Mobia Medical Inc. (MOBI) carries a Roarable Rating of D (Sell) with 46/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (46/100 · D) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D • SELL / AVOID Cap $375.2M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $11.16 (-0.98%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 10/20 (D) • 0.3% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (46/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-6.1% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-5.4% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for MOBI)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (46/100 Composite)

🔍 WHY MOBI SCORES 46/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (28% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▲ #2 Bullish Driver: Cash Engine Quality+10/20 pts (22% of score)

SEC XBRL FY 2025 (10-K): 0.3% FCF Margin ($10.5M FCF) & 52% Gross Margin

▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$8.63-6.3% Next Q

Q2 (-2Q)

Grade D$8.09+28.7% Next Q

Q3 (-1Q)

Grade D$10.41+8.3% Next Q

Current

Grade D$11.27-6.1% Hist 90D α

Trajectory: E (38) → D (46)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a MOBI Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While MOBI currently carries a cautious 46/100 (D) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($10.01) and Max Pain ($11.83) forces dealer call-delta covering toward $16.05.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (-0.40% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $MOBI• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “MOBI Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 46%NO 54%Trade / Inspect Odds →

VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL • FY 2025 (10-K)

How MOBI Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$10.5M (0.3% FCF Margin)

Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory

■ Revenue■ Net Profit■ Free Cash Flow

FY25

Rev $4.00B

Fiscal Year	Revenue	Gross Margin	Op Margin	Net Profit	Free Cash Flow	ROIC %
FY 2025	$4.00B	52%	0%	$0	$0	15%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring MOBI)

✓Walkthrough of MOBI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

MOBI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -4.09%▼ DESCENDING CHANNEL

2026-10-30O $11.28H $11.34L $10.53C $11.27VOL 143.3K

RES: $11.99SUP: $7.26SMA50: $10.01SMA200: $11.43

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

MOBI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 MOBI Butterfly Map → + Track MOBI →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on MOBI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for MOBI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for MOBI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (MOBI)

Health Care Rank #451 of 1016 ⚔️ EMBC vs MOBI Full Matrix →

1. Head-to-Head Health Care Peer Comparison (MOBI vs. EMBC, CLPT, OFIX, SI)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Mobia Medical Inc. (MOBI) ranks #451 by composite RQD confidence (46/100, grade D) and #488 by equity capitalization ($375.2M). Within this direct 5-issuer industry benchmark cohort, EMBC leads on earnings valuation at 3.9x trailing P/E, while EMBC leads on capital efficiency and profitability with 35.5% ROIC and 62.6% gross margin. EMBC currently holds the highest overall quantitative score in the immediate peer group at 74/100 (B) compared with MOBI at 46/100 (D).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
MOBI ACTIVE Mobia Medical Inc.	D	46/100	—	—	—	-4.41%	$375.2M	Benchmark Subject
EMBC Embecta Corp.	B	74/100	3.9x	62.6%	35.5%	+1.55%	$371.7M	/embc-vs-mobi →
CLPT ClearPoint Neuro Inc.	E	34/100	—	61.4%	-35.0%	+1.23%	$342.7M	/clpt-vs-mobi →
OFIX Orthofix Medical Inc.	D+	55/100	—	68.8%	-12.2%	+1.99%	$417.1M	/ofix-vs-mobi →
SI Shoulder Innovations Inc.	D-	42/100	—	76.5%	-16.1%	+4.93%	$425.5M	/si-vs-mobi →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2025–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001489993

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Mobia Medical Inc. (MOBI) reported GAAP revenue of $0 , GAAP net income of $0, operating cash flow of $0, and free cash flow of $0 . On the balance sheet, MOBI closed FY2025 with $48.1M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: N/A).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$0	$0	—	—	$48.1M	—

3. MOBI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is MOBI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Mobia Medical Inc. (NASDAQ: MOBI) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 46/100 at a spot price of $11.27 (-4.41% 1D, market cap $375.2M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 4/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, MOBI ranks #451 in composite RQD confidence.

How does MOBI compare to EMBC and CLPT in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), MOBI carries a Roarable D (46/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, EMBC (Embecta Corp.) holds a B grade (74/100 RQD, P/E 3.9x, ROIC 35.5%, cap $371.7M) and CLPT (ClearPoint Neuro Inc.) posts a E grade (34/100 RQD, P/E N/A, ROIC -35.0%, cap $342.7M). Among the 5-stock peer group, EMBC leads on earnings multiple (3.9x) while EMBC leads on capital efficiency (35.5% ROIC).

What are the biggest fundamental strengths and SEC risk factors for MOBI?

Per MOBI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001489993), Mobia Medical Inc. generated $0 in revenue, $0 in net income, and $0 in free cash flow against $48.1M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is MOBI trading relative to its 50-day, 200-day, and 52-week technical levels?

MOBI last traded at $11.27 (-4.41% on volume of 132,650 shares), positioning the stock +12.59% above its 50-day simple moving average ($10.01) and -1.40% below its 200-day simple moving average ($11.43). Across its 52-week range of $8.03 to $15.29, MOBI sits at the 44.6% percentile with a 14-day RSI of 56.1 (BULLISH MOMENTUM) and an implied next-earnings move of ±12.5% ($9.86 to $12.68).

MOBI Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

How profitable is Mobia Medical Inc. (MOBI)?

In FY 2025 (10-K), MOBI converted $4.0B of revenue into a 52% gross margin, 0% operating margin, and $10.5M in free cash flow (0.3% FCF margin).

Direct Sub-Reports: MOBI RQD Cockpit MOBI 12M Forecast MOBI Earnings & Move MOBI Dividends & DRIP MOBI Insiders & 13F MOBI Whale Options MOBI Profit Sankey MOBI News & Why